Delivery Order SPE2DB24D2003-SPE2DB25FXLM9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $7,489.37 and an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $2,954.20. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,477.10 and an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle with the Defense Logistics Agency. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $1,995.42. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive procurement executed through an existing contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,766.06 to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $1,954.60 with a firm fixed price structure. The order is scheduled for completion by September 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, non-set-aside award issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs at a ceiling value of $1,249.34. This competitive award, which requires completion by August 26, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $2,729.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $2,024.38. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a standard pharmaceutical supply transaction under the company's broader relationship with DLA. The award carries no set-aside designation, indicating competitive procurement among qualified vendors....
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLM9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,007.70 and an ultimate completion date of August 11, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor specializing in medical procurement for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 billion through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The epinephrine auto-injector delivery aligns with the company's extensive portfolio of federal medical supplies, which includes specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/8/25 |